The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality [0.03%]
维生素D对死亡率影响的随机对照试验(D-Health试验)
Rachel E Neale,Catherine Baxter,Briony Duarte Romero et al.
Rachel E Neale et al.
Background: The effect of supplementing unscreened adults with vitamin D3 on mortality is unclear. We aimed to determine whether monthly doses of vitamin D3 influenced mortality in older Australians. ...
Randomized Controlled Trial
The lancet. Diabetes & endocrinology. 2022 Feb;10(2):120-128. DOI:10.1016/S2213-8587(21)00345-4 2022
Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data [0.03%]
高收入国家糖尿病患者全因死亡率的多国综合数据分析及趋势分析
Dianna J Magliano,Lei Chen,Bendix Carstensen et al.
Dianna J Magliano et al.
Background: Population-level trends in mortality among people with diabetes are inadequately described. We aimed to examine the magnitude and trends in excess all-cause mortality in people with diabetes. ...
Jennifer Manne-Goehler,David Flood
Jennifer Manne-Goehler
Bernadette Biondi,Anne R Cappola
Bernadette Biondi
Subclinical hypothyroidism, which is defined as a thyroid-stimulating hormone concentration higher than the reference range (generally 4·5 mIU/L or higher) with normal free thyroxine concentrations, is frequently found in older individuals...
Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial [0.03%]
长效奥曲肽与注射类生长抑素受体配体治疗肢端肥大症患者的维持疗效：一项随机对照的三期多中心试验
Maria Fleseriu,Alexander Dreval,Irina Bondar et al.
Maria Fleseriu et al.
Background: Despite biochemically responding to injectable somatostatin receptor ligands (iSRLs), many patients with acromegaly experience treatment burdens. We aimed to assess maintenance of biochemical response and symp...
The pathogenesis, natural history, and treatment of type 1 diabetes: time (thankfully) does not stand still [0.03%]
1型糖尿病的发病机制、自然病程和治疗：时间（万幸的是）并未停滞不前
Aaron W Michels,Maria J Redondo,Mark A Atkinson
Aaron W Michels
J Jaime Miranda,Anne-Marie Thow,María Kathia Cárdenas et al.
J Jaime Miranda et al.
Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia [0.03%]
有效的降低中度至重度甘油三酯血症患者血脂的临床治疗方案
Gary F Lewis,Robert A Hegele
Gary F Lewis
Plasma triglyceride concentration is easily, inexpensively, and accurately measured, and when elevated is a highly informative disease marker that identifies individuals who frequently have a host of underlying metabolic, inflammatory, and ...
Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' reply [0.03%]
达格列净用于新冠肺炎患者：注意肾脏功能——作者回应
Mikhail N Kosiborod,Russell Esterline,Jan Oscarsson et al.
Mikhail N Kosiborod et al.